Nano-X Imaging (NNOX) Amortization of Goodwill (2022)

Nano-X Imaging (NNOX) posted quarterly Amortization of Goodwill of $36.5 million for Q4 2022, down 28.69% on a QoQ basis from $51.2 million in Q2 2022.

Nano-X Imaging (NNOX) Amortization of Goodwill (2022) Analysis & Trends

Nano-X Imaging (NNOX) has reported Amortization of Goodwill for 1 consecutive years, with $36.5 million the latest figure, recorded in Q4 2022.

  • Quarterly Amortization of Goodwill changed N/A year-over-year to $36.5 million in Q4 2022, while the trailing twelve-month figure through Dec 2023 was $87.8 million (changed N/A YoY) and the FY2023 annual result came in at $7.4 million, down 85.42% from the prior year.
  • Amortization of Goodwill eased to $36.5 million in Q4 2022 per NNOX's latest filing, from $51.2 million in the prior quarter.
  • Over the last five years, Amortization of Goodwill for NNOX reached as high as $51.2 million in Q2 2022 and fell as low as $36.5 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Nano-X Imaging 67.53 Mn 23.68 Mn -2.59 Mn

Historic Data

Download Data
DateValue
Dec 31, 2022 36.54 Mn
Dec 31, 2022 36.54 Mn
Jun 30, 2022 51.24 Mn
Jun 30, 2022 51.24 Mn